News
GlobalData on MSN2mon
FDA grants ODD status to Zai Lab’s lung cancer treatmentZai Lab global research and development head and ... The designation is granted based on promising data from the ongoing Phase Ia/Ib global trial of ZL-1310 in patients with extensive-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback